These guidelines outline recommendations for the management of patients with AL amyloidosis, including treatment, monitoring and how to measure response.
Guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance
These guidelines, written by the UK Myeloma Forum in conjunction with the Nordic Myeloma Study Group provide guidance for the effective clinical investigation of patients with newly detected paraprotein and the practical management of patients with monoclonal gammopathy of undetermined significance (MGUS).Download
IMWG Consensus perspectives: risk factors for progression and guidelines for monitoring and management of MGUS and smouldering myeloma
In this article, members of the International Myeloma Working Group review the available data and provide new recommendations for the management of MGUS and smouldering myeloma patients.Read abstract
Plasma cell leukaemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the IMWG
This article, written by the International Myeloma Working Group, reviews the evidence and provides a consensus on the diagnostic criteria, response criteria and treatment recommendations for primary plasma cell leukemia.Download